You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 29 No. 2, August 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Phenothiazine Effects in Good Premorbid Schizophrenics Divided Into Paranoid-Nonparanoid Status

Lewis L. Judd, MD; Michael J. Goldstein, PhD; Eliot H. Rodnick, PhD; Newton L.P. Jackson, Jr., PhD

Arch Gen Psychiatry. 1973;29(2):207-211.


Abstract

Twenty-four good premorbid schizophrenics, divided on the basis of paranoid-nonparanoid status, were studied under a double-blind design for differential responses to a phenothiazine medication while receiving drug and placebo regimens.

Autonomic responsivity levels measured by skin resistance and related to drug status did not distinguish between the paranoid-nonparanoid status patients. Significant findings emerged in the interactions between paranoid-nonparanoid status and the drug-placebo condition on only the cognitive and perceptual measures.

The paranoid patient on placebo status consistently did very poorly in both the clinical ratings and the experimental tasks. The nonparanoid patients showed only mild-to-moderate improvement effects while receiving medication and the performance of the nonparanoid receiving placebo was often very similar to that of the paranoid given drugs.

The findings of this study and others emphasize the importance of using the paranoid-nonparanoid and good-poor premorbid groupings when doing clinical and experimental research on schizophrenics.



Author Affiliations

San Diego, Calif

From the Department of Psychiatry, School of Medicine, University of California, San Diego (Dr. Judd), and the Department of Psychology, University of California, Los Angeles (Drs. Goldstein, Rodnick, and Jackson).


Footnotes

Accepted for publication Feb 22, 1973.

Reprint requests to the Department of Psychiatry, University of California, San Diego, PO Box 109, La Jolla, CA 92037 (Dr. Judd).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Phenothiazine Effects on Psychological and Psychophysiological Dysfunction in Chronic Schizophrenics
Spohn et al.
Arch Gen Psychiatry 1977;34:633-644.
ABSTRACT  

Very Short-Term Memory Dysfunction in Schizophrenia: Defective Short Time Constant Information Processing in Schizophrenia
Braff et al.
Arch Gen Psychiatry 1977;34:25-30.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.